Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down Syndrome

Journal of Investigative Medicine

Volumn 49, Issue 1, 2001, Pages 41-46

  Gulesserian, T ^a   Seidl, R ^a   Hardmeier, R ^a   Cairns, N ^a   Lubec, G ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Alzheimer disease; Brain; Down Syndrome; MALDI MS; SOD1; SOD2; Two dimensional electrophoresis

Indexed keywords

SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; BRAIN; CELL LOSS; CELL PROLIFERATION; CHROMOSOME 21; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; GENE OVEREXPRESSION; GLIA CELL; HUMAN; HUMAN TISSUE; MALE; OCCIPITAL CORTEX; OXIDATIVE STRESS; PARIETAL LOBE; TEMPORAL LOBE;

EID: 0035144524     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/6650.2001.34089     Document Type: Article

References (24)

1. Lipid peroxidation and superoxide dismutase-1 and glutathione peroxidase activities in trisomy 16 fetal mice and human trisomy 21 fibroblasts
2. Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down's syndrome fetal brain
3. Changes in the levels of enzymes which modulate the antioxidant balance occur during aging and correlate with cellular damage
4. Cu/Zn-superoxide dismutase and glutathione peroxidase during aging
5. Dosage effects for superoxide dismutase-1 on nucleated cells aneuploid for chromosome 21
6. Increase in glutathione peroxidase activity in erythrocytes from trisomy 21 subjects
7. Evidence against the involvement of reactive oxygen species in the pathogenesis of neuronal death in Down's syndrome and Alzheimer's disease
8. Oxidative stress and neural dysfunction in Down Syndrome
9. Reversible impairment of long term potentiation in transgenic Cu/Zn-SOD mice
10. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation
11. Age-related changes in antioxidant enzymes and lipid peroxidation in brains of control and transgenic mice overexpressing copper-zinc superoxide dismutase
12. A highly sensitive non-radioactive cytotoxicity assay for human target cells
13. Neuropathology of Down Syndrome
14. The consortium to establish a registry for Alzheimer disease (CERAD). II. Standardization of the neuropathological assessment of Alzheimer's disease
15. The NINCDA-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease
16. Identification of proteins by matrix-assisted laser desorption ionization-mass spectrometry following in-gel digestion in low salt, nonvolatile buffer and simplified peptide recovery
17. Two-dimensional map of human brain proteins
18. Apoptosis and increased generation of active oxygen species in Down's syndrome neurons in vitro
19. Manganese superoxide dismutase mediates the early release of mitochondrial cytochrome c and subsequent DNA fragmentation after permanent focal cerebral ischemia in mice
20. Effects of overexpression of the cytoplasmic copper-zinc superoxide dismutase on the survival of neurons in vitro
21. Overexpression of Cu-Zn-superoxide dismutase reduces hippocampal injury after global ischemia in transgenic mice
22. Elevated "hydroxyl radical" generation in vivo in animal model of amyotrophic lateral sclerosis
23. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down Syndrome and Alzheimer's disease